Key facts
- This page summarizes Vance Cushman Johnston's Form 4 filing for GoHealth, Inc. (GOCO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Dec 2021, 15:11.
Vance Cushman Johnston - 21 Dec 2021 Form 4 Insider Report for GoHealth, Inc. (GOCO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- GOCO
- Reported as of
- 21 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Dec 2021, 15:11:33 UTC
- Prior SEC filing
- 02 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Farley, Attorney-in-fact for Vance Johnston
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Vance Cushman Johnston filed Form 4 for GoHealth, Inc. (GOCO) on 22 Dec 2021.
Change
- Previous filing in this sequence was filed on 02 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GOCO
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +281,690
- Change %
- Price
- $0.000000
- Shares after
- 281,690
- Date
- 21 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GOCO
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +438,099
- Change %
- Price
- Shares after
- 438,099
- Date
- 21 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 438,099
- Exercise price
- $3.55
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a grant of restricted stock units which vest in three equal annual installments, with the first such installment vesting on December 7, 2022.
Footnote F2
The stock option vests in three equal annual installments, with the first such annual installment vesting on December 7, 2022.